Analyst Recommendation: Deutsche Bank has reiterated a "Buy" recommendation for British American Tobacco p.l.c. - Depositary Receipt (NYSE:BTI) as of November 28, 2025, with an average one-year price target of $59.49/share, indicating a potential upside of 1.42%.
Institutional Ownership Growth: There has been a notable increase in institutional ownership of BTI, with 901 funds reporting positions, a 6.12% rise from the previous quarter, and total shares owned by institutions increasing by 5.52% to 382,052K shares.
Positive Fund Sentiment: The put/call ratio for BTI stands at 0.61, suggesting a bullish outlook among investors, with several major funds increasing their allocations significantly over the last quarter.
Projected Financial Performance: British American Tobacco p.l.c. is projected to achieve annual revenue of $31,773 million, reflecting a 24.13% increase, with a non-GAAP EPS forecast of 4.87.
Wall Street analysts forecast BTI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTI is 62.00 USD with a low forecast of 62.00 USD and a high forecast of 62.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast BTI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTI is 62.00 USD with a low forecast of 62.00 USD and a high forecast of 62.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 53.790
Low
62.00
Averages
62.00
High
62.00
Current: 53.790
Low
62.00
Averages
62.00
High
62.00
Kepler Cheuvreux
Emanuele Sartori
Buy
initiated
£4,900
2025-12-12
Reason
Kepler Cheuvreux
Emanuele Sartori
Price Target
£4,900
2025-12-12
initiated
Buy
Reason
Kepler Cheuvreux analyst Emanuele Sartori initiated coverage of British American Tobacco with a Buy rating and 4,900 GBp price target. The firm says British American is a global leader in nicotine with a region- and product-driven model that prioritizes key brands to achieve strong consumer retention and deliver high shareholder returns.
Morgan Stanley
Rashad Kawan
Underweight
maintain
2025-12-10
Reason
Morgan Stanley
Rashad Kawan
Price Target
2025-12-10
maintain
Underweight
Reason
Morgan Stanley analyst Rashad Kawan raised the firm's price target on British American Tobacco to 3,050 GBp from 3,000 GBp and keeps an Underweight rating on the shares.
Deutsche Bank
Damian McNeela
Buy
upgrade
2025-11-28
Reason
Deutsche Bank
Damian McNeela
Price Target
2025-11-28
upgrade
Buy
Reason
Deutsche Bank analyst Damian McNeela raised the firm's price target on British American Tobacco to 4,900 GBp from 4,400 GBp and keeps a Buy rating on the shares.
Citi
NULL -> Buy
maintain
2025-11-28
Reason
Citi
Price Target
2025-11-28
maintain
NULL -> Buy
Reason
Citi raised the firm's price target on British American Tobacco to 4,850 GBp from 4,450 GBp and keeps a Buy rating on the shares.
About BTI
British American Tobacco p.l.c. is a global multi-category consumer goods business company. The Company provides tobacco and nicotine products. Its segments include the United States, Asia Pacific Middle East and Africa, and Americas and Europe. Its product categories include Vapor, Heating Products (HPs), Modern Oral, Traditional Oral, and Combustible cigarettes. Vapor products are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, known as vapor. HPs are devices that use heat to generate a nicotine-containing aerosol, which the user inhales. This category includes Tobacco Heated Products and Herbal Products for Heating (HPH). Modern Oral products are smoke-free oral nicotine products called nicotine pouches, designed for use in the mouth. Traditional oral products include snus and snuff. Its brands include Vuse, glo, Velo, Grizzly, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, Camel, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
